Laminopathies: Involvement of structural nuclear proteins in the pathogenesis of an increasing number of human diseases

Journal of Cellular Physiology

Volumn 203, Issue 2, 2005, Pages 319-327

  Maraldi, Nadir M ^a,b,c   Squarzoni, Stefano ^a   Sabatelli, Patrizia ^a   Capanni, Cristina ^b   Mattioli, Elisabetta ^b   Ognibene, Andrea ^b   Lattanzi, Giovanna ^a  

^a CNR   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HELICASE; LAMIN A; LAMIN B; LAMIN C; MEVINOLIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; EMERY DREIFUSS MUSCULAR DYSTROPHY; GENE; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC DISORDER; GENETIC TRANSCRIPTION; HEREDITARY MOTOR SENSORY NEUROPATHY; HETEROCHROMATIN; LAMINOPATHY; LMNA GENE; MISSENSE MUTATION; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; WERNER SYNDROME;

ACTINS; ANIMALS; CHROMATIN; GENE EXPRESSION REGULATION; GENES, REGULATOR; GENETIC DISEASES, INBORN; HUMANS; LAMINS; NUCLEAR ENVELOPE; NUCLEAR PROTEINS;

EID: 16344392142     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20217     Document Type: Review

References (126)

1. Agarwal AK, Fryns JP, Auchus RJ, Garg A. 2003. Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum Mol Genet 12:1995-2000.
2. Bengtsson L, Wilson KL. 2004. Multiple and surprising new functions for emerin, a nuclear membrane protein. Curr Opin Cell Biol 16:73-79.
3. Bergo MO, Gavino B, Ross J, Schmidt WK, Hong C, Kendall LV, Mohr A, Mete M, Genant H, Jiang Y, Wisner ER, Van Bruggen N, Carano RA, Michaelis S, Griffey SM, Young SG. 2002. Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc Natl Acad Sci USA 99:13049-13054.
4. Bione S, Maestrini E, Rivella S, Mancini M, Regis S, Toniolo D. 1994. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet 8:323-327.
5. Bonne G, Raffaele Di Barletta M, Varnous S, Becane HM, Hammouda EH, Merlini L, Muntoni F, Greenberg GR, Gary F, Urtizberea JA, Duboc D, Fardeau M, Toniolo D, Schwartz K. 1999. Mutations in the gene encoding lamin A/C cause autosomal dominant EDMD. Nat Genet 21:285-288.
6. Bonne G, Mercuri E, Muchir A, Urtizberea A, Becane HM, Recan D, Merlini L, Wehnert M, Boor R, Reuner U, Vorgerd M, Wicklein EM, Eymard B, Duboc D, Penisson-Besnier I, Cuisset JM, Ferrer X, Desguerre I, Lacombe D, Bushby K, Pollitt C, Toniolo D, Fardeau M, Schwartz K, Muntoni F. 2000. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol 48:170-180.
7. Bonne G, Capeau J, De Visser M, Duboc D, Merlini L, Morris GE, Muntoni F, Recan D, Sewry C, Squarzoni S, Stewart C, Talim B, van der Kooi A, Worman H, Schwartz K. 2002. 82nd ENMC international workshop, 5th international Emery-Dreifuss muscular dystrophy (EDMD) workshop, 1st Workshop of the MYO-CLUSTER project EUROMEN (European muscle envelope nucleopathies), 15-16 September 2000, Naarden, The Netherlands. Neuromuscul Disord 12:187-194.
8. Boronenkov IV, Loijens JC, Umeda M, Anderson RA. 1998. Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing pre-mRNA processing factors. Mol Biol Cell 9:3547-3560.
9. Boyer LA, Peterson CL. 2000. Actin-related proteins (Arps): Conformational switches for chromatin-remodeling machines? Bioessays 22:666-672.
10. Brodsky GL, Muntoni F, Miocic S, Sinagra G, Sewry C, Mestroni L. 2000. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 101:473-476.
11. Burke B, Stewart CL. 2002. Life at the edge: The nuclear envelope and human disease. Nat Rev Mol Cell Biol 3:575-585.
12. Cao H, Hegele RA. 2000. Nuclear lamin A/C R482Q mutation in Canadian kindred with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 9:109-112.
13. Cao H, Hegele RA. 2003. LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090). J Hum Genet 48:271-274.
14. Capanni C, Cenni V, Mattioli E, Sabatelli P, Ognibene A, Columbaro M, Parnaik VK, Wehnert M, Maraldi NM, Squarzoni S, Lattanzi G. 2003. Failure of lamin A/C to functionally assemble in R482L mutated familial partial lipodystrophy fibroblasts: Altered intermolecular interaction with emerin and implications for gene transcription. Exp Cell Res 291:122-134.
15. Caux F, Dubosclard E, Lascols O, Buendia B, Chazouilleres O, Cohen A, Courvalin JC, Laroche L, Capeau J, Vigouroux C, Christin-Maitre S. 2003. A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomela-nodermic papules, liver steatosis, and cardiomyopathy. J Clin Endocrinol Metab 88:1006-1013.
16. Chen L, Lee L, Kudlow BA, Dos Santos HG, Sletvold O, Shafeghati Y, Botha EG, Garg A, Hanson NB, Martin GM, Mian IS, Kennedy BK, Oshima J. 2003. LMNA mutations in atypical Werner's syndrome. Lancet 362:440-445.
17. Cohen M, Lee KK, Wilson KL, Gruenbaum Y. 2001. Transcriptional repression, apoptosis, human disease and the functional evolution of the nuclear lamina. Trends Biochem Sci 26:41-47.
18. Csoka AB, Cao H, Sammak PJ, Constantinescu D, Schatten GP, Hegele RA. 2004. Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes. J Med Genet 41:304-308.
19. Dalkilic I, Kunkel LM. 2003. Muscular dystrophies: Genes to pathogenesis. Curr Opin Genet Dev 13:231-238.
20. De Sandre-Giovannoli A, Chaouch M, Kozlov S, Vallat JM, Tazir M, Kassouri N, Szepetowski P, Hammadouche T, Vandenberghe A, Stewart CL, Grid D, Levy N. 2002. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet 70:726-736.
21. De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M, Levy N. 2003. Lamin a truncation in Hutchinson-Gilford progeria. Science 300:2055.
22. Dhe-Paganon S, Werner ED, Chi YI, Shoelson SE. 2002. Structure of the globular tail of nuclear lamin. J Biol Chem 277:17381-17384.
23. Dreuillet C, Tillit J, Kress M, Ernoult-Lange M. 2002. In vivo and in vitro interaction between human transcription factor MOK2 and nuclear lamin A/C. Nucleic Acids Res 30:4634-4642.
24. Emery AE. 2000. Emery-Dreifuss muscular dystrophy - A 40 year retrospective. Neuromuscul Disord 10:228-232.
25. Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Bobbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M, Glover TW, Collins FS. 2003. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423:293-298.
26. Fairley EA, Kendrick-Jones J, Ellis JA. 1999. The Emery-Dreifuss muscular dystrophy phenotype arises from aberrant targeting and binding of emerin at the inner nuclear membrane. J Cell Sci 112:2571-2582.
27. Fatkin D, Mac Rae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, Atherton J, Vidaillet HJ, Jr., Spudich S, De Girolami U, Muehle G, Seidman C, Muntoni F, Johnson W, Mcdonough B. 1999. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. New Engl J Med 341:1715-1724.
28. Favreau C, Dubosclard E, Ostlund C, Vigouroux C, Capeau J, Wehnert M, Higuet D, Worman HJ, Courvalin JC, Buendia B. 2003. Expression of lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with Dunnigan-type partial lipodystrophy and Emery-Dreifuss muscular dystrophy. Exp Cell Res 282:14-23.
29. Fidzianska A, Toniolo D, Hausmanowa-Petrusewicz I. 1998. Ultrastructural abnormality of sarcolemmal nuclei in Emery-Dreifuss muscular dystrophy (EDMD). J Neurol Sci 159:88-93.
30. Frankel S, Sigel EA, Craig C, Elgin SC, Mooseker MS, Artavanis-Tsakonas S. 1997. An actin-related protein in Drosophila colocalizes with heterochromatin protein 1 in pericentric heterochromatin. J Cell Sci 110:1999-2012.
31. Furukawa K. 1999. LAP2 binding protein 1 (L2BP1/BAF) is a candidate mediator of LAP2-chromatin interaction. J Cell Sci 112:2485-2492.
32. Garg A, Speckman RA, Bowcock AM. 2002. Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene. Am J Med 112:549-555.
33. Goldman RD, Gruenbaum Y, Moir RD, Shumaker DK, Spann TP. 2002. Nuclear lamins: Building blocks of nuclear architecture. Genes Dev 16:533-547.
34. Gonsior SM, Platz S, Buchmeier S, Scheer U, Jockusch BM, Hinssen H. 1999. Conformational difference between nuclear and cytoplasmic actin as detected by a monoclonal antibody. J Cell Sci 112:797-809.
35. Haraguchi T, Holaska JM, Yamane M, Koujin T, Hashiguchi N, Mori C, Wilson KL, Hirabka Y. 2004. Emerin binding to Btf, a death-promoting transcriptional represser, is disrupted by a missense mutation that causes Emery-Dreifuss muscular dystrophy. Eur J Biochem 271:1035-1045.
36. Hegele RA. 2001. Molecular basis of partial lipodystrophy and prospects for therapy. Trends Mol Med 7:121-126.
37. Hoffmann K, Dreger CK, Olins AL, Olins DE, Shultz LD, Lucke B, Karl H, Kaps R, Muller D, Vaya A, Aznar J, Ware RE, Sotelo Cruz N, Lindner TH, Herrmann H, Reis A, Sperling K. 2002. Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huet anomaly). Nat Genet 31:410-414.
38. Hofmann W, Reichart B, Ewald A, Muller E, Schmitt I, Stauber RH, Lottspeich F, Jockusch BM, Scheer U, Hauber J, Dabauvalle MC. 2001. Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)-containing retroviral RNAs. An unexpected role for actin. J Cell Biol 152:895-910.
39. Holaska JM, Wilson KL, Mansharamani M. 2002. The nuclear envelope, lamins and nuclear assembly. Curr Opin Cell Biol 14:357-364.
40. Holaska JM, Lee KK, Kowalski AK, Wilson KL. 2003. Transcriptional repressor germ cell-less (GCL) and barrier to autointegration factor (BAF) compete for binding to emerin in vitro. J Biol Chem 278:6969-6975.
41. Holt MR, Koffer A. 2001. Cell motility: Proline-rich proteins promote protrusions. Trends Cell Biol 11:38-46.
42. Holt I, Ostlund C, Stewart CL, Man N, Worman HJ, Morris GE. 2003. Effect of pathogenic mis-sense mutations in lamin A on its interaction with emerin in vivo. J Cell Sci 116:3027-3035.
43. Horton JD. 2002. Sterol regulatory element-binding proteins: Transcriptional activators of lipid synthesis. Biochem Soc Trans 30:1091.
44. Huang C, Sloan EA, Boerkoel CF. 2003. Chromatin remodeling and human disease. Curr Opin Genet Dev 13:246-252.
45. Hutchison CJ. 2002. Lamins: Building blocks or regulators of gene expression? Nat Rev Mol Cell Biol 3:848-858.
46. Hutchison CJ, Alvarez-Reyes M, Vaughan OA. 2001. Lamins in disease: Why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes? J Cell Sci 114:9-19.
47. Kapiloff MS, Schillace RV, Westphal AM, Scott JD. 1999. mAKAP: An A-kinase anchoring protein targeted to the nuclear membrane of differentiated myocytes. J Cell Sci 112:2725-2736.
48. Krauss SW, Chen C, Penman S, Heald R. 2003. Nuclear actin and protein 4.1: Essential interactions during nuclear assembly in vitro. Proc Natl Acad Sci USA 100:10752-10757.
49. Krimm I, Ostlund C, Gilquin B, Couprie J, Hossenlopp P, Mornon JP, Bonne G, Courvalin JC, Worman HJ, Zinn-Justin S. 2002. The Ig-like structure of the C-terminal domain of lamin A/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy. Structure 10:811-823.
50. Kumaran RI, Muralikrishna B, Parnaik VK. 2002. Lamin A/C speckles mediate spatial organization of splicing factor compartments and RNA polymerase II transcription. J Cell Biol 159:783-793.
51. Lallena MJ, Martinez C, Valcarcel J, Correas I. 1998. Functional association of nuclear protein 4.1 with pre-mRNA splicing factors. J Cell Sci 111:1963-1971.
52. Lammerding J, Schulze PC, Takahashi T, Kozlov S, Sullivan T, Kamm RD, Stewart CL, Lee RT. 2004. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 113:370-378.
53. Lattanzi G, Cenni V, Marmiroli S, Capanni C, Mattioli E, Merlini L, Squarzoni S, Maraldi NM. 2003. Association of emerin with nuclear and cytoplasmic actin is regulated in differentiating myoblasts. Biochem Biophys Res Commun 3033:764-770.
54. Lloyd DJ, Trembath RC, Shackleton S. 2002. A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum Mol Genet 11:769-777.
55. Manilal S, Nguyen TM, Sewry C, Morris GE. 1996. The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein. Hum Mol Gen 5:801-808.
56. Manilal S, Sewry CA, Pereboev A, Man N, Gobbi P, Hawkes S, Love DH, Morris GE. 1999. Distribution of emerin and lamins in the heart and implications for Emery-Dreifuss muscular dystrophy. Hum Mol Genet 8:353-359.
57. Maraldi NM, Zini N, Santi S, Manzoli FA. 1999. Topology of inositol lipid signal transduction in the nucleus. J Cell Physiol 181:203-217.
58. Maraldi NM, Lattanzi G, Sabatelli P, Ognibene A, Squarzoni S. 2002. Functional domains of the nucleus: Implications for Emery-Dreifuss muscular dystrophy. Neuromuscul Disord 12:815-823.
59. Maraldi NM, Lattanzi G, Sabatelli P, Ognibene A, Columbaro M, Capanni C, Rutigliano C, Mattioli E, Squarzoni S. 2003. Immunocytochemistry of nuclear domains and Emery-Dreifuss muscular dystrophy pathophysiology. Eur J Histochem 47:3-16.
60. Markiewicz E, Dechat T, Foisner R, Quinlan RA, Hutchison CJ. 2002. Lamin A/C binding protein LAP2alpha is required for nuclear anchorage of retinoblastoma protein. Mol Biol Cell 13:4401-4413.
61. Mattout-Drubezki A, Gruenbaum Y. 2003. Dynamic interactions of nuclear lamina proteins with chromatin and transcriptional machinery. Cell Mol Life Sci 60:2053-2063.
62. Mislow JM, Kim MS, Davis DB, McNally EM. 2002. Myne-1, a spectrin repeat transmembrane protein of the myocyte inner nuclear membrane, interacts with lamin A/C. J Cell Sci 115:61-70.
63. Moir HD, Spann TP. 2001. The structure and function of nuclear lamins: Implications for disease. Cell Mol Life Sci 58:1748-1757.
64. Moir RD, Spann TP, Lopez-Soler RI, Yoon M, Goldman AE, Khuo S, Goldberg RD. 2000. Review: The dynamics of the nuclear lamins during the cell cycle. Relationship between structure and function. J Struct Biol 129:324-334.
65. Morris GE. 2000. Nuclear proteins and cell death in inherited neuromuscular disease. Neuromuscul Disord 10:217-227.
66. Morris GE, Manilal S. 1999. Heart to heart: From nuclear proteins to Emery-Dreifuss muscular dystrophy. Hum Mol Genet 8:1847-1851.
67. Mounkes LC, Burke B, Stewart CL. 2001. The A-type lamins: Nuclear structural proteins as a focus for muscular dystrophy and cardiovascular diseases. Trends Cardiovasc Med 11:280-285.
68. Mounkes LC, Kozlov S, Hernandez L, Sullivan T, Stewart CL. 2003. A progeroid syndrome in mice is caused by defects in A-type lamins. Nature 423:298-301.
69. Muchir A, Bonne G, Van Der Kooj AJ, Van Meegen M, Baas F, Bolhuis PA, De Visser M, Schwartz K. 2000. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limbgirdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet 9:1453-1459.
70. Muchir A, van Engelen BG, Lammens M, Mislow JM, McNally E, Schwartz K, Bonne G. 2003. Nuclear envelope alterations in fibroblasts from LGMD1B patients carrying nonsense Y259X heterozygous or homozygous mutation in lamin A/C gene. Exp Cell Res 291:352-362.
71. Nagano A, Arahata K. 2000. Nuclear envelope proteins and associated diseases. Curr Opin Neurol 13:533-539.
72. Nagano A, Koga R, Ogawa M, Kurano Y, Kawada J, Okada R, Hayashi YK, Tsukahara T, Arahata K. 1996. Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy. Nat Genet 12:254-259.
73. Nebl G, Meuer SC, Samstag Y. 1996. Dephosphorylation of serine 3 regulates nuclear translocation of cofilin. J Biol Chem 271:26276-26280.
74. Neely KE, Workman JL. 2002. Histone acetylation and chromatin remodeling: Which comes first? Mol Genet Metab 76:1-5.
75. Nikolova V, Leimena C, McMahon AC, Tan JC, Chandar S, Jogia D, Kesteven SH, Michalicek J, Otway R, Verheyen F, Rainer S, Stewart CL, Martin D, Feneley MP, Fatkin D. 2004. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J Clin Invest 113:357-369.
76. Novelli G, Muchir A, Sangiuolo F, Helbling-Leclerc A, D'Apice MR, Massart C, Capon F, Sbraccia P, Federici M, Lauro R, Tudisco C, Pallotta R, Scarano G, Dallapiccola B, Merlini L, Bonne G. 2002. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am J Hum Genet 71:426-431.
77. Ognibene A, Sabatelli P, Petrini S, Squarzoni S, Riccio M, Santi S, Villanova M, Palmeri S, Merlini L, Maraldi NM. 1999. Nuclear changes in a case of X-linked Emery-Dreifuss muscular dystrophy. Muscle Nerve 22:864-869.
78. Okorokov AL, Rubbi CP, Metcalfe S, Milner J. 2002. The interaction of p53 with the nuclear matrix is mediated by F-actin and modulated by DNA damage. Oncogene 21:356-367.
79. Olave IA, Reck-Peterson SL, Crabtree GR. 2002. Nuclear actin and actin-related proteins in chromatin remodeling. Annu Rev Biochem 71:775-781.
80. Onoda K, Yin HL. 1993. gCap39 is phosphorylated. Stimulation by okadaic acid and preferential association with nuclei. J Biol Chem 268:4106-4112.
81. Östlund C, Ellenberg J, Hallberg E, Lippincott-Schwartz J, Worman HJ. 1999. Intracellular trafficking of emerin, the Emery-Dreifuss muscular dystrophy protein. J Cell Sci 112:1709-1719.
82. Östlund C, Bonne G, Schwartz K, Worman HJ. 2001. Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy. J Cell Sci 114:4435-4445.
83. Pederson T, Aebi U. 2002. Actin in the nucleus: What form and what for? J Struct Biol 140:3-9.
84. Pendas AM, Zhou Z, Cadinanos J, Freije JM, Wang J, Hultenby K, Astudillo A, Wernerson A, Rodriguez F, Tryggvason K, Lopez-Otin C. 2002. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet 31:94-99.
85. Percipalle P, Zhao J, Pope B, Weeds A, Lindberg U, Daneholt B. 2001. Actin bound to the heterogeneous nuclear ribonucleoprotein hrp36 is associated with Balbiani ring mRNA from the gene to polysomes. J Cell Biol 153:229-236.
86. Percipalle P, Jonsson A, Nashchekin D, Karlsson C, Bergman T, Guialis A, Daneholt B. 2002. Nuclear actin is associated with a specific subset of hnRNP A/B-type proteins. Nucleic Acids Res 30:1725-1734.
87. Pierce T, Worman HJ, Holy J. 1999. Neuronal differentiation of NT2/D1 teratocarcinoma cells is accompanied by a loss of lamin A/C expression and an increase in lamin B1 expression. Exp Neurol 157:241-250.
88. Raffaele Di Barletta M, Ricci E, Galluzzi G, Tonali P, Mora M, Morandi L, Romorini A, Voit T, Orstavik KH, Merlini L, Trevisan C, Biancalana V, Hausmanowa-Petrusewicz I, Bione S, Ricotti R, Schwartz K, Bonne G, Toniolo D. 2000. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Hum Genet 66:1407-1412.
89. Raharjo WH, Enarson P, Sullivan T, Stewart CL, Burke B. 2001. Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy. J Cell Sci 114:4447-4457.
90. Rando OJ, Zhao K, Crabtree GR. 2000. Searching for a function for nuclear actin. Trends Cell Biol 10:92-97.
91. Reyes JC, Barra J, Muchardt C, Camus A, Babinet C, Yaniv M. 1998. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2alpha). EMBO J 17:6979-6991.
92. Sabatelli P, Lattanzi G, Ognibene A, Columbaro M, Capanni C, Merlini L, Maraldi NM, Squarzoni S. 2001. Nuclear alterations in autosomal-dominant Emery-Dreifuss muscular dystrophy. Muscle Nerve 24:826-829.
93. Sasseville AM, Langelier Y. 1998. In vitro interaction of the carboxy-terminal domain of lamin A with actin. FEBS Lett 425:485-489.
94. Sasseville AM, Raymond Y. 1995. Lamin A precursor is localized to intranuclear foci. J Cell Sci 108:273-285.
95. Sebillon P, Bouchier C, Bidot LD, Bonne G, Ahamed K, Charron P, Drouin-Garraud V, Millaire A, Desrumeaux G, Benaiche A, Charniot JC, Schwartz K, Villard E, Komajda M. 2003. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. J Med Genet 40:560-567.
96. Shen X, Xiao H, Ranallo R, Wu WH, Wu C. 2003. Modulation of ATP-dependent chromatin-remodeling complexes by inositol polyphosphates. Science 299:112-114.
97. Shumaker DK, Kuczmarski ER, Goldman RD. 2003. The nucleoskeleton: Lamins and actin are major players in essential nuclear functions. Curr Opin Cell Biol 15:358-366.
98. Simha V, Garg A. 2002. Body fat distribution and metabolic derangements in patients with familial partial lipodystrophy associated with mandibuloacral dysplasia. J Clin Endocrinol Metab 87:776-785.
99. Sinensky M, McLain T, Fantle K. 1994. Expression of prelamin A but not mature lamin A confers sensitivity of DNA biosynthesis to lovastatin on F9 teratocarcinoma cells. J Cell Sci 107:2215-2218.
100. Skare P, Kreivi JP, Bergstrom A, Karlsson H. 2003. Profilin I colocalizes with speckles and Cajal bodies: A possible role in pre-mRNA splicing. Exp Cell Res 286:12-21.
101. Sotiropoulos A, Gineitis D, Copeland J, Treisman R. 1999. Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98:159-169.
102. Spann TP, Goldman AE, Wang C, Huang S, Goldman RD. 2002. Alteration of nuclear lamin organization inhibits RNA polymerase II-dependent transcription. J Cell Biol 156:603-608.
103. Speckman RA, Garg A, Du F, Bennett L, Veile R, Arioglu E, Taylor SI, Lovett M, Bowcock AM. 2000. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am J Hum Genet 66:1192-1198.
104. Squarzoni S, Sabatelli P, Ognibene A, Toniolo D, Cartegni L, Cobianchi F, Petrini S, Merlini L, Maraldi NM. 1998. Immunocytochemical detection of emerin within the nuclear matrix. Neuromuscul Disord 8:338-344.
105. Steen RL, Collas P. 2001. Mistargeting of B-type lamins at the end of mitosis: Implications on cell survival and regulation of lamins A/C expression. J Cell Biol 153:621-626.
106. Steger DJ, Haswell ES, Miller AL, Wente SR, O'Shea EK. 2003. Regulation of chromatin remodeling by inositol polyphosphates. Science 299:114-116.
107. Stierlé V, Couprie J, Ostlund C, Krimm I, Zinn-Justin S, Hossenlopp P, Worman HJ, Courvalin JC, Duband-Goulet I. 2003. The carboxyl-terminal region common to lamins A and C contains a DNA binding domain. Biochemistry 42:4819-4828.
108. Straub V, Campbell KP. 1997. Muscular dystrophies and the dystrophin-glycoprotein complex. Curr Opin Neurol 10:168-175.
109. Stuurman N, Heins S, Aebi U. 1998. Nuclear lamins: Their structure, assembly, and interactions. J Struct Biol 122:42-66.
110. Sullivan T, Escalante-Alcalde D, Bhatt H, Anver M, Bhat N, Nagashima K, Stewart CL, Burke B. 1999. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 47:913-920.
111. Toniolo D, Minetti C. 1999. Muscular dystrophies: Alterations in a limited number of cellular pathways? Curr Opin Genet Dev 9:275-282.
112. Tsuchiya Y, Hase A, Ogawa M, Yorifuji H, Arahata K. 1999. Distinct regions specify the nuclear membrane targeting of emerin, the responsible protein for Emery-Dreifuss muscular dystrophy. Eur J Biochem 259: 859-865.
113. Tsukahara T, Tsujino S, Arahata K. 2002. CDNA microarray analysis of gene expression in fibroblasts of patients with X-linked Emery-Dreifuss muscular dystrophy. Muscle Nerve 25:898-901.
114. Tzur YB, Hersh BM, Horvitz HH, Gruenbaum Y. 2002. Fate of the nuclear lamina during Caenorhabditis elegans apoptosis. J Struct Biol 137:146-153.
115. Vigouroux C, Auclair M, Dubosclard E, Pouchelet M, Capeau J, Courvalin JC, Buendia B. 2001. Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene. J Cell Sci 114:4459-4468.
116. Vlcek S, Korbei B, Foisner R. 2002. Distinct functions of the unique C terminus of LAP2alpha in cell proliferation and nuclear assembly. J Biol Chem 277:18898-18907.
117. Wang W, Cote J, Xue Y, Zhou S, Khavari PA, Biggar SR, Muchardt C, Kalpana GV, Goff SP, Yaniv M, Workman JL, Crabtree GR. 1996. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J 15:5370-5382.
118. Wang X, Xu S, Rivolta C, Li LY, Peng GH, Swain PK, Sung CH, Swaroop A, Berson EL, Dryja TP, Chen S. 2002. Barrier to autointegration factor interacts with the cone-rod homeobox and represses its transactivation function. J Biol Chem 277:43288-43300.
119. Waterham HR, Koster J, Mooyer P, Noort Gv G, Kelley RI, Wilcox WR, Wanders RJ, Hennekam RC, Oosterwijk JC. 2003. Autosomal recessive HEM/Greenberg skeletal dysplasia is caused by 3 beta-hydroxysterol delta 14-reductase deficiency due to mutations in the lamin B receptor gene. Am J Hum Genet 72:1013-1017.
120. Wilkinson FL, Holaska JM, Zhang Z, Sharma A, Manilal S, Holt I, Stamm S, Wilson KL, Morris GE. 2003. Emerin interacts in vitro with the splicing-associated factor, YT521-B. Eur J Biochem 270:2459-2466.
121. Wilson KL. 2000. The nuclear envelope, muscular dystrophy and gene expression. Trends Cell Biol 10:125-129.
122. Ye Q, Callebaut I, Pezhman A, Courvalin JC, Worman HJ. 1997. Domain-specific interactions of human HP1-type chromodomain proteins and inner nuclear membrane protein LBR. J Biol Chem 272:14983-14989.
123. Yuan J, Simos G, Blobel G, Georgatos SD. 1991. Binding of lamin A to polynucleosomes. J Biol Chem 266:9211-9215.
124. Zastrow MS, Vlcek S, Wilson KL. 2004. Proteins that bind A-type lamins: Integrating isolated clues. J Cell Sci 117:979-987.
125. Zhang Q, Skepper JN, Yang F, Davies JD, Hegyi L, Roberts RG, Weissberg PL, Ellis JA, Shanahan CM, 2001. Nesprins: A novel family of spectrin-repeat-ontaining proteins that localize to the nuclear membrane in multiple tissues. J Cell Sci 114:4485-4498.
126. Zhao K, Wang W, Rando OJ, Xue Y, Swiderek K, Kuo A, Crabtree GR. 1998. Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell 95:625-636.